TriangleNCT01772719 · OUTCOME
Duration of Response
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Year 3-5 follow up visit occurs every six months
What was measured
Response will be assessed by one of the study investigators at each six month follow up visit for Year 3-5
Analysis population: Study was terminated and PI has left the institution. Sincere efforts were made to gather and report the data, however, no data is available for the study
Groups in this outcome
Study Arm
Study Arm Simvastatin and zoledronic acid: 1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy. 2\. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.
| Group | Source count |
|---|---|
| Study Arm | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- Response will be assessed by one of the study investigators at each six month follow up visit for Year 3-5
- groups
- description
- Study Arm Simvastatin and zoledronic acid: 1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy. 2\. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.
- id
- OG000
- title
- Study Arm
- population Description
- Study was terminated and PI has left the institution. Sincere efforts were made to gather and report the data, however, no data is available for the study
- reporting Status
- POSTED
- time Frame
- Year 3-5 follow up visit occurs every six months
- title
- Duration of Response
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice